JOHN LAWRENCE: Open Payments
NPI 1235401712 · GAYLORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,547 in 105 payments from 17 companies in 2025. Trend: 2023 $1,398 · 2024 $1,900 · 2025 $2,547
Food & beverage: $2,547
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $637 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $511 |
| ABBVIE INC. | 20 | $307 |
| PFIZER INC. | 12 | $243 |
| Axsome Therapeutics, Inc. | 4 | $200 |
| Vanda Pharmaceuticals Inc. | 14 | $172 |
| Novo Nordisk Inc | 2 | $145 |
| Lilly USA, LLC | 4 | $77 |
| Astellas Pharma US Inc | 4 | $77 |
| Lundbeck LLC | 1 | $32 |
Products named: CAPLYTA, AIRSUPRA, Auvelity, BREZTRI, UBRELVY, FANAPT, Ozempic, NEXIUM.
Industry payments across MI — which companies pay providers there.
